Students issued a cumulative recommendation regarding the application of Silagene’s U1 Adaptor technology to therapeutic targets. Students evaluated the technical feasibility of gene targets based on gain-of-function evidence and associated disease epidemiology. Students constructed financial models highlighting the commercial opportunity of various disease indications.
- Student Externs: Odhran King (Lead), Rajan Verma, Olivia Paulin
- Mentors: Patrick Nosker, PhD and Bill Koski